Clinical trial · Interventional
Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema
Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema: Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study was conducted: * To investigate the effect of MLS Laser in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment. * To investigate the effect of CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment. * To compare the effect of MLS Laser versus CCT in the management of patients with unilateral BCRL regarding lymphatic flow, volumetric measurement and HRQL assessment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphedema | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cold Compression therapy | Device | — | UNRESOLVED |
| complete decongestive therapy | Other | — | UNRESOLVED |
| Multi-waved Locked System Laser | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Study group (A) Multi-waved Locked System Laser group
- interventionNames
- Device: Multi-waved Locked System Laser
- Other: complete decongestive therapy
- type
- EXPERIMENTAL
- label
- Study group (B) Cold Compression Therapy group
- interventionNames
- Device: Cold Compression therapy
- Other: complete decongestive therapy
- type
- ACTIVE_COMPARATOR
- label
- Group (C) Control group
- interventionNames
- Other: complete decongestive therapy
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female patients with unilateral BCRL. * Age of patients above 18 years old * Patient history of modified radical mastectomy, chemotherapy and/or radiotherapy. * Patients undertaken have history or current hormonal treatment. * Patients with moderate lymphoedema (20-40% increase in extremity volume) Exclusion Criteria: * Patients who have severe co-morbid diseases. * Presence of other cancers, cancer recurrence, lymphatic malformation, or vascular disease * Patients who are having current chemotherapy and/or radiotherapy. * Patients who have bilateral lymphedema, current metastases, elephantiasis, infection, lymphangiosis carcinomatosa, cellulitis, venous thrombosis, or congestive heart failure * Patients with musculoskeletal disorders affecting upper extremity.
References
Publications (0)
Data not yet available